- Report
- November 2023
- 200 Pages
Global
From €5715EUR$5,950USD£4,920GBP
- Report
- February 2024
- 175 Pages
Global
From €4802EUR$5,000USD£4,134GBP
- Report
- October 2023
- 180 Pages
Global
From €4706EUR$4,900USD£4,052GBP
- Report
- August 2023
- 173 Pages
Global
From €4706EUR$4,900USD£4,052GBP
- Report
- April 2024
- 183 Pages
Global
From €4706EUR$4,900USD£4,052GBP
- Report
- December 2023
- 140 Pages
Global
From €4274EUR$4,450USD£3,680GBP
- Report
- January 2024
- 250 Pages
Global
€4798EUR$4,995USD£4,130GBP
- Report
- November 2022
- 418 Pages
Global
From €2350EUR$2,621USD£2,094GBP
- Report
- April 2024
- 185 Pages
From €4706EUR$4,900USD£4,052GBP
- Book
- April 2010
- 512 Pages
The RNA Biology market is a subset of the larger Genomics market, focusing on the study of ribonucleic acid (RNA). RNA is a molecule that plays a key role in the regulation of gene expression, and is involved in a variety of biological processes, including protein synthesis, gene regulation, and cell signaling. RNA Biology research is used to understand the role of RNA in disease, and to develop new treatments and diagnostics.
The RNA Biology market is composed of a variety of companies, including those that develop and manufacture reagents and instruments for RNA research, as well as those that provide services such as sequencing and bioinformatics. Examples of companies in the market include Thermo Fisher Scientific, Illumina, Agilent Technologies, Bio-Rad Laboratories, and QIAGEN. Show Less Read more